Metaglidasen was a fibrate-like drug candidate developed by Metabolex, Inc. that acts as a selective receptor modulator of the peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor involved in regulating genes linked to glucose and lipid metabolism.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.